Focus shifts to antibody cocktails for COVID-19 cytokine storm

C Harrison - Nature biotechnology, 2020 - go.gale.com
On June 5 the Ministry of Health of the Russian Federation registered Biocad's Ilsira
(levilimab) as a treatment for severe COVID-19. Ilsira is one of several monoclonal …
被引用次数：50 相关文章

[引用][C] Focus shifts to antibody cocktails for COVID-19 cytokine storm

C Harrison - Nature biotechnology, 2020 - pubmed.ncbi.nlm.nih.gov
Focus shifts to antibody cocktails for COVID-19 cytokine storm Focus shifts to antibody
cocktails for COVID-19 cytokine storm Nat Biotechnol. 2020 Aug;38(8):905-908. doi …

[引用][C] Focus shifts to antibody cocktails for COVID-19 cytokine storm.

C Harrison - Nature Biotechnology, 2020 - europepmc.org
Focus shifts to antibody cocktails for COVID-19 cytokine storm. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …